Important advances in 2014 foster new perspectives on definitions of early and end-stage disease, and promote a shift in the clinical management of osteoarthritis (OA) through implementing treatment algorithms intended to minimize strain on current health-care models. Collectively, these changes shed new light on developing and optimizing approaches to OA treatment.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Cross, M. et al. The global burden of hip and knee osteoarthritis: estimates from the Global Burden of Disease 2010 study. Ann. Rheum. Dis. 73, 1323–1330 (2014).
Hunter, D. J., Schofield, D. & Callander, E. The individual and socioeconomic impact of osteoarthritis. Nat. Rev. Rheumatol. 10, 437–441 (2014).
Hunter, D. J. Lower extremity osteoarthritis management needs a paradigm shift. Br. J. Sports Med. 45, 283–288 (2011).
Sharma, L. et al. Significance of pre-radiographic MRI lesions in persons at higher risk for knee osteoarthritis. Arthritis Rheum. 66, 1811–1819 (2014).
Riddle, D. L., Perera, R. A., Jiranek, W. A. & Dumenci, L. Using surgical appropriateness criteria to examine outcomes of total knee arthroplasty in a United States sample. Arthritis Care Res. (Hoboken) http://dx.doi.org/10.1002/acr.22428.
McAlindon, T. E. et al. OARSI guidelines for the non-surgical management of knee osteoarthritis. Osteoarthritis Cartilage 22, 363–388 (2014).
Escobar, A. et al. Development of explicit criteria for total knee replacement. Int. J. Technol. Assess. Health Care 19, 57–70 (2003).
Losina, E., Thornhill, T. S., Rome, B. N., Wright, J. & Katz, J. N. The dramatic increase in total knee replacement utilization rates in the United States cannot be fully explained by growth in population size and the obesity epidemic. J. Bone Joint Surg. Am. 94, 201–207 (2012).
Losina, E. et al. Lifetime medical costs of knee osteoarthritis management in the United States: Impact of extending indications for total knee arthroplasty. Arthritis Care Res. (Hoboken) http://dx.doi.org/10.1002/acr.22412.
Health Information and Quality Authority (HIQA). Health Technology Assessment of Scheduled Procedures: arthroplasty for osteoarthritis of the knee [online] (2014).
Acknowledgements
D.J.H. is supported by a National Health and Medical Research Council Practitioner Fellowship.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
D.J.H. receives royalties from DJO in relation to sales of a patellofemoral brace. R.F.M. declares no competing interests.
PowerPoint slides
Rights and permissions
About this article
Cite this article
Moyer, R., Hunter, D. Changing how we define and treat patients with OA. Nat Rev Rheumatol 11, 65–66 (2015). https://doi.org/10.1038/nrrheum.2014.211
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrrheum.2014.211
This article is cited by
-
MicroRNA-99a regulates early chondrogenic differentiation of rat mesenchymal stem cells by targeting the BMPR2 gene
Cell and Tissue Research (2016)